Constraints on Regulatory Options for Putatively Cognitive Enhancing Drugs

REFERENCES

• Bell , S. K. , Lucke , J. C. and Hall , W. D. 2012 . Lessons for enhancement from the history of cocaine and amphetamine use . AJOB Neuroscience , 3 ( 2 ) : 24 – 29 .
   Google Scholar
• Darke , S. , Degenhardt , L. and Mattick , R. , eds. 2007 . Mortality amongst illicit drug users: Epidemiology, causes and intervention , Cambridge , , UK : Cambridge University Press .
   Google Scholar
• Dubljević , V. 2013 . Prohibition or coffee shops: Regulation of amphetamine and methylphenidate for enhancement use by healthy adults . American Journal of Bioethics , 13 ( 7 ) : 23 – 33 .
   PubMed Web of Science ®Google Scholar
• Greely , H. , Sahakian , B. Harris , J. 2008 . Towards responsible use of cognitive-enhancing drugs by the healthy . Nature , 456 ( 7223 ) : 702 – 705 .
   PubMed Web of Science ®Google Scholar
• Hall , W. D. 2004 . Feeling ‘better than well’: Can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? . EMBO Reports , 5 ( 12 ) : 1105 – 1109 .
   PubMed Web of Science ®Google Scholar
• Hall , W. D. and Degenhardt , L. 2007 . Regulating opioid prescribing to provide access to effective treatment while minimising diversion: An overdue topic for research . Addiction , 102 : 1685 – 1688 .
   PubMed Web of Science ®Google Scholar
• Hall , W. D. and Farrell , M. 2011 . Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia . Medical Journal of Australia , 195 : 248 – 249 .
   PubMed Web of Science ®Google Scholar
• Harris , J. 2009 . Enhancing evolution: The ethical case for making better people , Princeton , NJ : Princeton University Press .
   Google Scholar
• Harris , J. and Quigley , M. 2008 . Humans have always tried to improve their condition . Nature , 451 ( 7178 ) : 521
   PubMed Web of Science ®Google Scholar
• Klee , H. , ed. 1997 . Amphetamine misuse: International perspectives on current trends , Reading , , UK : Harwood Academic .
   Google Scholar
• Larriviere , D. , Williams , M. , Rizzo , M. and Bonnie , R. 2009 . Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee . Neurology , 73 ( 17 ) : 1406 – 1412 .
   PubMed Web of Science ®Google Scholar
• Lucke , J. , Partridge , B. , Racine , E. and Forlini , C. 2013 . “ Using neuropharmaceuticals for cognitive enhancement: Policy and regulatory issues ” . In Handbook of neuroethics , Edited by: Clausen , J. and Levy , N. The Netherlands: Springer . In press
   Google Scholar
• Lucke , J. C. , Bell , S. , Partridge , B. and Hall , W. D. 2011 . Deflating the neuroenhancement bubble . AJOB Neuroscience , 2 ( 4 ) : 38 – 43 .
   Google Scholar
• McKetin , R. , Sutherland , R. , Bright , D. and Norberg , M. 2011 . A systematic review of methamphetamine precursor regulations . Addiction , 106 ( 11 ) : 1911 – 1924 .
   PubMed Web of Science ®Google Scholar
• Okie , S. 2010 . A flood of opioids, a rising tide of deaths . New England Journal of Medicine , 363 ( 21 ) : 1981 – 1985 .
   PubMed Web of Science ®Google Scholar
• Rasmussen , N. 2008 . On speed: The many lives of amphetamine , New York , NY : New York University Press .
   Google Scholar
• Repantis , D. , Schlattmann , P. , Laisney , O. and Heuser , I. 2010 . Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review . Pharmacological Research , 62 ( 3 ) : 187 – 206 .
   PubMed Web of Science ®Google Scholar
• Room , R. 2012 . Reform by subtraction: The path of denunciation of international drug treaties and reaccession with reservations . International Journal of Drug Policy , 23 ( 5 ) : 401 – 406 .
   PubMed Web of Science ®Google Scholar
• Room , R. , Fischer , B. , Hall , W. D. , Lenton , S. and Reuter , P. , eds. 2010 . Cannabis policy: Moving beyond stalemate , Oxford , , UK : Oxford University Press .
   Google Scholar
• Room , R. and Reuter , P. 2012 . How well do international drug conventions protect public health? . Lancet , 379 ( 9810 ) : 84 – 91 .
   PubMed Web of Science ®Google Scholar
• Singleton , J. , Degenhardt , L. , Hall , W. D. and Zabransky , T. 2009 . Mortality among amphetamine users: A systematic review of cohort studies . Drug and Alcohol Dependence , 105 ( 1–2 ) : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Strang , J. , Babor , T. Caulkins , J. 2012 . Drug policy and the public good: Evidence for effective interventions . Lancet , 379 ( 9810 ) : 71 – 83 .
   PubMed Web of Science ®Google Scholar
• Van Zee , A. 2009 . The promotion and marketing of OxyContin: Commercial triumph, public health tragedy . American Journal of Public Health , 99 ( 2 ) : 221 – 227 .
   PubMed Web of Science ®Google Scholar
• Whitely , M. 2012 . The rise and fall of ADHD child prescribing in Western Australia: Lessons and implications . Australian and New Zealand Journal of Psychiatry , 46 ( 5 ) : 400 – 403 .
   PubMed Web of Science ®Google Scholar